INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
03/11/2026
Back to search
Official data from USPTO
CELLSPRESSO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CELLSPRESSO
ST13
US500000079223494Class
5, 10
Filing
79223494
Registration
5634962
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/12/2026
Trademark type
Word
Nice classes
5, 10
Filing date
07/24/2017
Registration date
12/25/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/11/2025
Last transaction
03/12/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
BERLIN, JUSTIN E
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cell Therapy Limited
Representatives
Melanie Howard Loeb & Loeb LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of diseased skintissueorgans and body parts in the nature of treatment for viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases; veterinary pharmaceutical preparations for the treatment of diseased skintissueorgans and body parts in the nature of treatment for viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases; pharmaceutical preparations and substances for the treatment of damaged skin and tissuetissue regenerative pharmaceutical preparations; cellular medicinesstem cells for medical or veterinary use; reagents for medical or veterinary use; clinical medical and veterinary reagents; medical and veterinary diagnostic reagents; reagents for medical and veterinary diagnosis and medical and veterinary diagnostic research; chemical reagents for testing aqueous solutions for medical and veterinary purposes; reagents for use in biological processing for medical and veterinary purposes; media for biological and bacteriological cultures for medical and veterinary use; non-aqueous solvents for use in tests for medical and veterinary purposes; aqueous solutions for use in tests for medical and veterinary purposes; non-aqueous culture media for medical and veterinary use; chemicals preparationsbuffer solutions for use in tests for medical and veterinary purposes; chemicalssurfactants for use in tests for medical and veterinary purposes
Class 10
Medical and veterinary devicesinstruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skintissueorgans and body parts; disposable cartridges for medical and veterinary devicesinstruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skintissueorgans and body parts; portable medical and veterinary apparatusinstruments for the preparation of regenerative cells for implantation into humans and animals for the treatment of damaged and diseased skintissueorgans and body parts; surgicalmedicalveterinary apparatusdevicesinstruments for use in implanting regenerative cells into humans and animals to treat damaged and diseased skintissueorgans and body parts; surgicalmedicalveterinary apparatusdevicesinstruments for use in cell therapy and regenerative medicine; medical and veterinary devicesapplicators to implant regenerative cells into humans and animals for the treatment of damaged and diseased skintissueorgans and body parts; sample preparation devices for medical diagnostic use; apparatus for the regeneration of stem cells for medical purposes; component parts and fittings for all of the aforesaid
Publications
History of USPTO decisions and trademark events.
33 publications found
C71T
CANCELLED SECTION 71
07/11/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/25/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/04/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/25/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/26/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/05/2019
FIMP
FINAL DISPOSITION PROCESSED
04/05/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/25/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
12/25/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/09/2018
PUBO
PUBLISHED FOR OPPOSITION
10/09/2018
GPNX
NOTIFICATION PROCESSED BY IB
10/06/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/19/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/19/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/28/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
08/03/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/03/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
08/03/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/03/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/19/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/18/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/18/2018
RFNP
REFUSAL PROCESSED BY IB
02/16/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/26/2018
RFRR
REFUSAL PROCESSED BY MPU
01/26/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/19/2018
CNRT
NON-FINAL ACTION WRITTEN
01/18/2018
MAFR
APPLICATION FILING RECEIPT MAILED
12/30/2017
DOCK
ASSIGNED TO EXAMINER
12/26/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/26/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/21/2017
Continuous trademark protection
Get notified about every new filing that threatens CELLSPRESSO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.